Initial Therapeutics

South San Francisco, United States

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

May 2023

Series A

Biotechnology Therapeutics

Top Investors

Apple Tree Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Initial Therapeutics

Who are Initial Therapeutics's investors?

Initial Therapeutics's investors include Apple Tree Partners.

Where is Initial Therapeutics headquartered?

Initial Therapeutics is headquartered in South San Francisco, United States.

What does Initial Therapeutics do?

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

What stage is Initial Therapeutics at?

Initial Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 1, 2023.

MLA

"Initial Therapeutics — Funding & Investors." VCBacked, May 1, 2023, https://www.vcbacked.co/company/initial-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). Initial Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/initial-therapeutics

Wikipedia (cite web)

{{cite web |title=Initial Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/initial-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 1, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.